Loading clinical trials...
Loading clinical trials...
A Single Arm, Open Label, Multicenter Exploratory Study of Apatinib in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Second Line Therapy
Conditions
Interventions
apatinib
Locations
4
China
the second hospital of Changzhou city
Changzhou, Jiangsu, China
Nanjing 81 Hospital
Nanjing, Jiangsu, China
the first affiliated hospital with Nanjing Medical University
Nanjing, Jiangsu, China
Jiangnan University affiliated hospital
Wuxi, Jiangsu, China
Start Date
July 1, 2017
Primary Completion Date
June 30, 2019
Completion Date
December 30, 2019
Last Updated
January 14, 2020
NCT06662786
NCT06663319
NCT05239741
NCT05770102
NCT04812912
NCT06778382
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions